FDA approves generic versions of Imitrex

2/12/2009

Jerusalem The Food and Drug Administration has approved Teva Pharmaceutical Industries’ generic version of GlaxoSmithKline’s Imitrex, Teva announced Wednesday.

Teva’s sumatriptan tablets will be available in 25-mg, 50-mg and 100-mg strengths, and have already begun to ship.

Sumatriptan is used to treat acute migraine attacks. The drug had sales of about $1 billion for the 12 months ending in December, according to IMS Health.

The FDA also approved Indian generic drug maker Ranbaxy’s version in the 100-mg strength and injected forms of sumatriptan from Teva and Wockhardt.

X
This ad will auto-close in 10 seconds